Visual cortex excitability and plasticity associated with remission from chronic to episodic migraine

Cephalalgia

Volumn 32, Issue 7, 2012, Pages 537-543

  Chen, Wei Ta ^a,b,c   Wang, Shuu Jiun ^a,b   Fuh, Jong Ling ^a,b   Ko, Yu Chieh ^a,b   Lee, Yi Chung ^a,b   Hämäläinen, Matti S ^c   Lin, Yung Yang ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

chronic migraine; magnetoencephalography; Migraine; topiramate; visual cortical excitability; visual evoked magnetic field

Indexed keywords

TOPIRAMATE;

ADULT; ARTICLE; CLINICAL ARTICLE; EPISODIC MIGRAINE; EVOKED VISUAL RESPONSE; EXCITABILITY; FEMALE; HABITUATION; HUMAN; MAGNETOENCEPHALOGRAPHY; MALE; NERVE CELL PLASTICITY; NERVE STIMULATION; REMISSION; TRANSFORMED MIGRAINE; TREATMENT DURATION; VISUAL CORTEX;

ADULT; ANTICONVULSANTS; CHRONIC DISEASE; EVOKED POTENTIALS, VISUAL; FEMALE; FOLLOW-UP STUDIES; FRUCTOSE; HUMANS; MAGNETOENCEPHALOGRAPHY; MALE; MIGRAINE DISORDERS; NEURONAL PLASTICITY; REMISSION INDUCTION; VISUAL CORTEX; YOUNG ADULT;

EID: 84861810247     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102412443337     Document Type: Article

References (29)

1. Dodick DW. Clinical practice. Chronic daily headache. N Engl J Med. 2006 ; 354: 158-165
2. Aurora SK, Barrodale P, Chronicle EP, et al. Cortical inhibition is reduced in chronic and episodic migraine and demonstrates a spectrum of illness. Headache. 2005 ; 45: 546-552
3. Coppola G, Pierelli F, Schoenen J. Habituation and migraine. Neurobiol Learn Mem. 2009 ; 92: 249-259
4. Höffken O, Stude P, Lenz M, et al. Visual paired-pulse stimulation reveals enhanced visual cortex excitability in migraineurs. Eur J Neurosci. 2009 ; 30: 714-720
5. Schoenen J, Ambrosini A, Sándor PS, et al. Evoked potentials and transcranial magnetic stimulation in migraine: published data and viewpoint on their pathophysiologic significance. Clin Neurophysiol. 2003 ; 114: 955-972
6. Chen WT, Wang SJ, Fuh JL, et al. Peri-ictal normalization of visual cortex excitability in migraine: an MEG study. Cephalalgia. 2009 ; 29: 1202-1211
7. Judit A, Sándor PS, Schoenen J. Habituation of visual and intensity dependence of auditory evoked cortical potentials tends to normalize just before and during the migraine attack. Cephalalgia. 2000 ; 20: 714-719
8. Sakai Y, Dobson C, Diksic M, et al. Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis. Neurology. 2008 ; 70: 431-439
9. Chen WT, Wang SJ, Fuh JL, et al. Persistent ictal-like visual cortical excitability in chronic migraine. Pain. 2011 ; 152: 254-258
10. Chen WT, Lin YY, Fuh JL, et al. Sustained visual cortex hyperexcitability in migraine with persistent visual aura. Brain. 2011 ; 134: 2387-2395
11. Schoenen J. Is chronic migraine a never-ending migraine attack?. Pain. 2011 ; 152: 239-240
12. Lu SR, Fuh JL, Chen WT, et al. Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia. 2001 ; 21: 980-986
13. Manack A, Buse DC, Serrano D, et al. Rates, predictors, and consequences of remission from chronic migraine to episodic migraine. Neurology. 2011 ; 76: 711-718
14. Fuh JL, Wang SJ, Lu SR, et al. A 13-year long-term outcome study of elderly with chronic daily headache. Cephalalgia. 2008 ; 28: 1017-1022
15. Wang SJ, Fuh JL, Lu SR. Chronic daily headache in adolescents: an 8-year follow-up study. Neurology. 2009 ; 73: 416-422
16. Welch KM, Nagesh V, Aurora SK, et al. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness?. Headache. 2001 ; 41: 629-637
17. Olesen J, Bousser MG, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006 ; 26: 742-746
18. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004 ; 24 (Suppl 1). S9 - S160
19. Aurora SK, Barrodale PM, Vermaas AR, et al. Topiramate modulates excitability of the occipital cortex when measured by transcranial magnetic stimulation. Cephalalgia. 2010 ; 30: 648-654
20. Aurora SK, Barrodale PM, Tipton RL, et al. Brainstem dysfunction in chronic migraine as evidenced by neurophysiological and positron emission tomography studies. Headache. 2007 ; 47: 996-1003
21. Bahra A, Matharu MS, Buchel C, et al. Brainstem activation specific to migraine headache. Lancet. 2001 ; 357: 1016-1017
22. Matharu MS, Bartsch T, Ward N, et al. Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain. 2004 ; 127: 220-230
23. Weiller C, May A, Limmroth V, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med. 1995 ; 1: 658-660
24. de Tommaso M, Guido M, Sardaro M, et al. Effects of topiramate and levetiracetam vs placebo on habituation of contingent negative variation in migraine patients. Neurosci Lett. 2008 ; 442: 81-85
25. Vollono C, Ferraro D, Miliucci R, et al. The abnormal recovery cycle of somatosensory evoked potential components in children with migraine can be reversed by topiramate. Cephalalgia. 2010 ; 30: 17-26
26. Reis J, Tergau F, Hamer HM, et al. Topiramate selectively decreases intracortical excitability in human motor cortex. Epilepsia. 2002 ; 43: 1149-1156
27. Inghilleri M, Gilio F, Conte A, et al. Topiramate and cortical excitability in humans: a study with repetitive transcranial magnetic stimulation. Exp Brain Res. 2006 ; 174: 667-672
28. Garnett WR. Clinical pharmacology of topiramate: a review. Epilepsia. 2000 ; 41 (Suppl 1). S61 - S65
29. Artemenko AR, Kurenkov AL, Filatova EG, et al. Effects of topiramate on migraine frequency and cortical excitability in patients with frequent migraine. Cephalalgia. 2008 ; 28: 203-208